# Trial to Evaluate The Efficacy Of Rotigotine on Parkinson's Disease-Associated Motor Symptoms And Apathy

> **NCT01782222** · PHASE4 · COMPLETED · sponsor: **UCB BIOSCIENCES GmbH** · enrollment: 122 (actual)

## Conditions studied

- Idiopathic Parkinson's Disease

## Interventions

- **DRUG:** Rotigotine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01782222
- **Lead sponsor:** UCB BIOSCIENCES GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2014-01
- **Final completion:** 2014-03
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2018-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01782222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01782222, "Trial to Evaluate The Efficacy Of Rotigotine on Parkinson's Disease-Associated Motor Symptoms And Apathy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01782222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*